Robust Bayesian monitoring of sequential trials
From MaRDI portal
Recommendations
Cites work
- scientific article; zbMATH DE number 3903818 (Why is no real title available?)
- scientific article; zbMATH DE number 1348603 (Why is no real title available?)
- A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models
- Design of Experiment for Bioassay
- Interim Analysis in Clinical Trials: The Role of the Likelihood Principle
- Optimal Experimental Design for Another's Analysis
- Ranges of posterior measures for priors with unimodal contaminations
- Robust Bayes and empirical Bayes analysis with \(\epsilon\)-contaminated priors
- Robust Bayesian analysis in medical and epidemiological settings
- Robust Bayesian analysis: sensitivity to the prior
- Robust Bayesian sample size determination for avoiding the range of equivalence in clinical trials
- Sample Size Determination for Robust Bayesian Analysis
This page was built for publication: Robust Bayesian monitoring of sequential trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q478376)